
News|Articles|September 1, 2002
Kytril Injection (Granisetron HCl) Hoffmann-La Roche
Serotonin 5-HT3 receptor now indicated for prevention/treatment of PONV
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Positive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025
2
Quadruplet treatments for multiple myeloma are rising but access varies | ASH 2025
3
AstraZeneca’s Imfinzi gains landmark FDA approval for early gastric and gastroesophageal cancers
4
IV iron treatment improves survival, increases hemoglobin levels in anemic patients with acute bacterial infection | ASH 2025
5






















































